The effect of endothelin and its antagonist Bosentan on hemodynamics and microvascular exchange in cirrhotic rat liver

Journal of Hepatology

Volumn 28, Issue 6, 1998, Pages 1020-1030

  Reichen, Jürg ^c   Gerbes, Alexander L ^a   Steiner, Markus J ^d   Sägesser, Hans ^d   Clozel, Martine ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

^d NONE

Author keywords

Cirrhosis; Microspheres; Multiple indicator dilution technique; Perfused liver; Plasma endothelin; Portal blood flow; Portal hypertension; Portal pressure

Indexed keywords

ALBUMIN; BOSENTAN; CARBON TETRACHLORIDE; ENDOTHELIN 1; PENTOBARBITAL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; BILIARY CIRRHOSIS; CONTROLLED STUDY; DOSE RESPONSE; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIVER CIRRHOSIS; LIVER PERFUSION; LIVER SINUSOID; LIVER TOXICITY; MALE; NONHUMAN; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL; RAT; STELLATE CELL;

EID: 0012236876     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80352-8     Document Type: Article

References (61)

1. Gandhi CR, Stephenson K, Olson MS. Endothelin - a potent peptide agonist in the liver. J Biol Chem. 265:1990;17432-17435.
2. Serradeil LeGal C, Jouneaux C, Sanchez Bueno A, Raufaste D, Roche B, Preaux AM, et al. Endothelin action in rat liver. J Clin Invest. 87:1991;133-138.
3. Hartleb M, Kirstetter P, Moreau P, Soupison T, Pussard E, Hadengue A, et al. Relationships between plasma endothelin concentrations and the severity of cirrhosis. Gastroenterol Clin Biol. 18:1994;407-412.
4. Matsumoto H, Uemasu J, Kitano M, Kawasaki H. Clinical significance of plasma endothelin-1 in patients with chronic liver disease. Dig Dis Sci. 39:1994;2665-2670.
5. Asbert M, Gines A, Ginés P, Jimenez W, Claria J, Salo J, et al. Circulating levels of endothelin in cirrhosis. Gastroenterology. 104:1992;1485-1491.
6. Uchihara M, Izumi N, Sato C, Marumo F. Clinical significance of elevated plasma endothelin concentration in patients with cirrhosis. Hepatology. 16:1992;95-99.
7. Isobe H, Satoh M, Sakai H, Nawata H. Increased plasma endothelin-1 levels in patients with cirrhosis and esophageal varices. J Clin Gastroenterol. 17:1993;227-230.
8. Veglio FG, Melchio R, Rabbia F, Panarelli M, Gagliardi B, Chiandussi L. Plasma endothelin levels in cirrhotic subjects. J Hepatol. 15:1992;85-87.
9. Hartleb M, Moreau R, Cailmail S, Gaudin C, Labrec D. Vascular hyporesponsiveness to endothelin 1 in rats with cirrhosis. Gastroenterology. 107:1994;1085-1093.
10. Yu PC, Kuo JS, Lin HC, Yang MCM. Effects of endothelin in portal hypertensive rats. Clin Sci. 83:1992;165-170.
11. Bauer M, Zhang JX, Bauer I, Clemens MG. ET-1 induced alterations of hepatic microcirculation: sinusoidal and extra-sinusoidal sites of action. Am J Physiol. 267:1994;G143-G149.
12. Rockey DC, Weisiger RA. Endotheliin induced contractility of stellate cells from normal and cirrhotic rat liver: implications for regulation of portal pressure and resistance. Hepatology. 24:1996;233-240.
13. Warner TD, Battistini B, Doherty AM, Corder R. Endothelin receptor antagonists: actions and rationale for their development. Biochem Pharmacol. 48:1994;625-635.
14. Goresky CA. A linear method for determining liver sinusoidal and extravascular volume. Am J Physiol. 204:1963;626-640.
15. Reichen J, Le M. Verapamil favourably influences hepatic microvascular exchange and function in rats with cirrhosis of the liver. J Clin Invest. 78:1986;448-455.
16. Clozel M, Breu V, Gray GA, Kalina B, Löffler BM, Burri K, et al. Pharmacological characterization of Bosentan, a new potent orally active nonpeptide endothelin receptor antagonist. J Pharmacol Exp Ther. 270:1994;228-235.
17. McLean EK, McLean AEM, Sutton PM. Instant cirrhosis. An improved method for producing cirrhosis of the liver in rats by simultaneous administration of carbon tetrachloride and phenobarbitone. Br J Exp Pathol. 50:1969;502-506.
18. Kontouras J, Billing BH, Scheuer PJ. Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat. Br J Exp Pathol. 65:1984;305-311.
19. Reichen J, Arts B, Schafroth U, Zimmermann A, Zeltner TB, Zysset T. Aminopyrine N-demethylation by rats with liver cirrhosis: evidence for the intact cell hypothesis. A morphometric-functional study. Gastroenterology. 93:1987;719-726.
20. Gross JB, Reichen J, Zeltner T, Zimmermann A. The evolution of changes in quantitative liver function tests in a rat model of cirrhosis: correlation with morphometric measurement of hepatocyte mass. Hepatology. 7:1987;457-463.
21. Groszman RJ, Vorobioff J, Riley E. Splanchnic hemodynamics in portal hypertensive rats: measurement with gamma-labeled microspheres. Am J Physiol. 242:1982;G156-G160.
22. Edmondson JW, Miller BA, Lumeng L. Effect of glucagon on hepatic taurocholate uptake: relationship to membrane potential. Am J Physiol. 249:1985;G427-G433.
23. Reichen J, Egger B, Ohara N, Zeltner TB, Zysset T, Zimmermann A. Determinants of hepatic functions in liver cirrhosis in the rat: a multivariate analysis. J Clin Invest. 82:1988;2069-2076.
24. Meier P, Zierler KL. On the theory of the indicator dilution method for measurement of blood flow and volume. J Appl Physiol. 6:1954;731-744.
25. Änggard E, Galton S, Rae G, Thomas R, McLoughlin L, de Nucci G, et al. The fate of radioiodinated endothelin-1 and endothelin-3 in the rat. J Cardiovasc Pharmacol. 13:1989;S46-S49.
26. Gerbes AL, Moller S, Gülberg V, Henriksen JH. Endothelin-1 and -3 plasma concentrations in patients with cirrhosis: role of splanchnic and renal passage and liver function. Hepatology. 21:1995;735-739.
27. Snedecor GW, Cochran WG. Statistical Methods. 1967;Iowa State University Press, Ames.
28. Kleinbaum DG, Kupper LL. Applied Regression Analysis and Other Multivariable Methods. 1978;Duxbury Press, North Scituate.
29. Ohara N, Schaffner T, Reichen J. Structure-function relationship in secondary biliary cirrhosis in the rat: stereologic and hemodynamic characterization of a model. J Hepatol. 17:1993;155-162.
30. Gall JA, Bhathal PS. A quantitative analysis of the liver following ligation of the common bile duct. Liver. 10:1990;116-125.
31. Tanaka A, Katagiri K, Hoshino M, Hayakawa T, Tsukada K, Takeuchi T. Endothelin-1 stimulates bile acid secretion and vesicular transport in the isolated perfused rat liver. Am J Physiol. 266:1994;G324-G329.
32. Bauer M, Zhang JX, Bauer I, Clemens MG. Endothelin-1 as a regulator of hepatic microcirculation: sublobular distribution of effects and impact on hepatocellular secretory function. Shock. 1:1994;457-465.
33. Goresky CA, Ziegler WH, Bach GG. Capillary exchange modelling. Barrier-limited and flow-limited distribution. Circ Res. 27:1970;739-764.
34. Varin F, Huet PM. Hepatic microcirculation in the perfused cirrhotic rat liver. J Clin Invest. 76:1985;1904-1912.
35. Gülberg V, Gerbes AL. Relation of endothelins to volume regulating neurohumoral systems in patients with cirrhosis of the liver. Eur J Clin Invest. 25:1995;893-898.
36. Saló J, Francitorra A, Follo A, Navasa M, Ginès A, Jiménez W, et al. Increased plasma endothelin in cirrhosis. Relationship with systemic endoteoxemia and response to changes in effective blood volume. J Hepatol. 22:1995;389-398.
37. Tsai YT, Lin HC, Yang MCM, Lee FY, Hou MC, Chen LS, et al. Plasma endothelin levels in patients with cirrhosis and their relationships to the severity of cirrhosis and renal function. J Hepatol. 23:1995;681-688.
38. Bernardi M, Gülberg V, Colantoni A, Trevisani F, Gasbarrini A, Gerbes AL. Plasma endothelin-1 and -3 in cirrhosis: relationship with systemic hemodynamics, renal function and neurohumoral systems. J Hepatol. 24:1996;161-168.
39. Gandhi CR, Sproat LA, Subbotin VM. Increased hepatic endothelin-1 levels and endothelin receptor density in cirrhotic rats. Life Sci. 58:1995;55-62.
40. Zhang JX, Pegoli W, Clemens MG. Endothelin-1 induces direct constriction of hepatic sinusoids. Am J Physiol. 266:1994;G624-G632.
41. Pinzani M, Milani S, De Franco R, Grappone C, Caligiuri A, Gentilini A, et al. Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells. Gastroenterology. 110:1996;534-548.
42. Leivas A, Jiménez W, Lamas S, Bosch-Marcé M, Oriola J, Clària J, et al. Endothelin 1 does not play a major role in the homeostasis of arterial pressure in cirrhotic rats with ascites. Gastroenterology. 108:1995;1842-1848.
43. Tran-Thi TA, Kawada N, Decker K. Regulation of endothelin-1 action on the perfused rat liver. FEBS Lett. 318:1993;353-357.
44. Housset C, Rockey DC, Bissell DM. Endothelin receptors in rat liver: lipocytes as a contractile target for endothelin 1. Proc Natl Acad Sci USA. 90:1993;9266-9270.
45. Rockey DC. Characterization of endothelin receptors mediating rat hepatic stellate cell contraction. Biochem Biophys Res Commun. 207:1995;725-731.
46. Gondo K, Ueno T, Sakamoto M, Sakisaka S, Sata M, Tanikawa K. The endothelin-1 binding site in rat liver tissue: light- and electron-microscopic autoradiographic studies. Gastroenterology. 104:1993;1745-1749.
47. Diamantis I, van de Casteele M, Hurni B, Reichen J. Detection of endothelin-1 and its receptors in rat liver endothelial cells by in situ reverse transcriptase-polymerase chain reaction. J Hepatol. 28:1998;157-160.
48. Eakes AT, Howard KM, Miller JE, Olson MS. Endothelin-1 production by hepatic endothelial cells: characterization and augmentation by endotoxin exposure. Am J Physiol Gastrointest Liver Physiol. 272:1997;G605-G611.
49. Zhang JX, Bauer M, Clemens MG. Vessel- and target cell-specific actions of endothelin-1 and endothelin-3 in rat liver. Am J Physiol Gastrointest Liver Physiol. 269:1995;G269-G277.
50. Desmarets J, Gresser O, Guedin D, Frelin C. Interaction of endothelin-1 with cloned bovine ETA receptors: biochemical parameters and functional consequences. Biochemistry. 35:1996;14868-14875.
51. Schaffner F, Popper H. Capillarization of hepatic sinusoids in man. Gastroenterology. 44:1963;239-242.
52. Marteau P, Ballet F, Chazouilleres O, Chretien Y, Rey C, Petit D, et al. Effect of vasodilators on hepatic microcirculation in cirrhosis: a study in the isolated perfused rat liver. Hepatology. 9:1989;820-823.
53. Bhathal PS, Grossman H. Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators. J Hepatol. 1:1985;325-337.
54. Reichen J, Hirlinger A, Ha HR, Saegesser H. Chronic verapamil administration lowers portal pressure and improves hepatic function in rats with liver cirrhosis. J Hepatol. 3:1986;49-58.
55. Villeneuve JP, Dagenais M, Huet PM, Roy A, Lapointe R, Marleau D. The hepatic microcirculation in the isolated perfused human liver. Hepatology. 23:1996;24-31.
56. Garcia-Pagan JC, Feu F, Luca A, Fernandez M, Pizcueta P, Bosch J, et al. Nicardipine increases hepatic blood flow and the hepatic clearance of indocyanine green in patients with cirrhosis. J Hepatol. 20:1994;792-796.
57. 4-induced liver injury. Eur J Pharmacol Environ Toxicol Pharmacol. 293:1995;361-368.
58. Mallat A, Fouassier L, Préaux A-M, Serradeil-Le Gal C, Raufaste D, Rosenbaum J, et al. Growth inhibitory properties of endothelin-1 in human hepatic myofibroblastic Ito cells. An endothelin B receptor-mediated pathway. J Clin Invest. 96:1995;42-49.
59. Claria J, Jimenez W, Arroyo V, Castro A, Asbert M, Ros J, et al. Doses of endothelin have natriuretic effects in conscious rats with cirrhosis and ascites. Kidney Int. 40:1991;182-187.
60. Braet F, De Zanger R, Baekeland M, Crabbé, Van Der Smissen P, Wisse E. Structure and dynamics of the fenestrae-associated cytoskeleton of rat liver sinusoidal endothelial cells. Hepatology. 21:1995;180-189.
61. Gatmaitan Z, Varticovski L, Ling L, Mikkelsen R, Steffan AM, Arias IM. Studies on fenestral contraction in rat liver endothelial cells in culture. Am J Pathol. 148:1996;2027-2041.